The pattern of topical corticosteroid prescribing in the United States, 1989-1991

Journal of the American Academy of Dermatology

Volumn 35, Issue 2 PART I, 1996, Pages 183-186

  Stern, Robert S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID; GENERIC DRUG;

ARTICLE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DERMATOLOGY; GENERAL PRACTITIONER; HUMAN; PEDIATRICIAN; PRESCRIPTION; PRIORITY JOURNAL; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADRENAL CORTEX HORMONES; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; DERMATOLOGIC AGENTS; DERMATOLOGY; DRUG COMBINATIONS; DRUG UTILIZATION; DRUGS, GENERIC; HUMANS; OFFICE VISITS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRESCRIPTIONS, DRUG; UNITED STATES;

EID: 0029765460     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90319-9     Document Type: Article

References (9)

1. Drug information for the health care professional, 1994; vol 1. Rockville, MD: United States Pharmacopeia, Inc, 1994:3351.
2. Stoughton RB. Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids: a direct comparison. Arch Dermatol 1969;99:753-6.
3. Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol 1985;121:63-7.
4. Beth Israel Hospital: drug dictionary. Boston: Clinical Computing System, 1995.
5. Delozier JE, Gagnon RO. National Ambulatory Medical Care Survey: 1989 summary. Vital and Health Statistics of the National Center for Health Statistics. No. 203. Hyattsville, MD: US Department Health and Human Services, 1994.
6. Stoughton RB. Are generic formulations equivalent to trade name topical glucocorticoids? Arch Dermatol 1987;123:1312-4.
7. Olsen EA. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. Arch Dermatol 1991;127:197-201.
8. Stoughton RB. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments. Int J Dermatol 1992;31:26-8.
9. Guin JD, Wallis MS, Walls R, et al. Quantitative vasoconstrictor assay for topical corticosteroids: the puzzling case of fluocinolone acetonide. J Am Acad Dermatol 1993;29:197-202.